HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...

Abbott (NYSE: ABT) today announced data from an acute clinical feasibility study of its Aveir Conduction System Pacing (CSP) ...

Medtronic (NYSE: MDT) today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

Abbott (NYSE: ABT) today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation ...

Medtronic (NYSE: MDT) announced a strategic agreement to distribute Dragonfly Endoscopy's Dragonfly pancreaticobiliary system ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse ...

Olympus announced today that it appointed Bob White, former Medtronic EVP, as its new CEO, effective June 1, 2025.

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...